Uk Healthcare and Pharmaceutical Market Analysis and Forecast to 2020

UK Healthcare And Pharmaceutical Market Regulatory & Reimbursement

Landscape Report Till 2020

GlobalData, the industry analysis specialist, has released its new report, “CountryFocus:

Healthcare, Regulatory and Reimbursement Landscape - UK”. The report is an essential source

of information and an analysis on the healthcare, regulatory and reimbursement landscape of the

UK. The report identifies the key trends in the healthcare market and provides insights on the

demographic, regulatory, reimbursement landscape and healthcare infrastructure of the UK.

Most importantly, the report provides valuable insights on the trends and segmentation of the

pharmaceutical and medical devices market. This report is built using data and information

sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s

team of industry experts.

In 2014, the UK`s population was approximately 64.2 million. The major factors contributing to

the growth in the population are increase in net migration and decrease in death rate. The UK

policymakers are now presented with the problems of a Eurozone crisis, a declining population

of the working age group and an increasing elderly population. The pharmaceutical market in the

UK was estimated at $28.8 billion in 2015 and is expected to reach approximately $43.2 billion

by 2020 with a projected Compound Annual Growth Rate (CAGR) of 8.4%. The medical

devices market size was approximately $14.4 billion in 2015 and is expected to reach

approximately $17.9 billion by 2020 with a projected CAGR of 4.5%.

To Get More Details @ http://www.radiantinsights.com/research/countryfocus-healthcareregulatory-and-reimbursement-landscape-uk

The positive trends in the UK healthcare market can be attributed primarily to - Increasing elderly population

- Universal healthcare insurance

- High degree of access to healthcare facilities

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of

the UK. The...